Interest

Avicanna Reports Full Year 2023 Audited Financial Results 

Retrieved on: 
Tuesday, April 2, 2024
Cream, Cannabidiol, Cannabinoid, Dravet syndrome, Brazilian Health Regulatory Agency, Interest, Medical cannabis, Seizure, Business, Lennox–Gastaut syndrome, Patient, Pharmacy, Active ingredient, Research, Acquisition, RDC, Ultra, Stock, CBD, Insurance, Health Canada, Bank statement, GMP, Dermatology, TSX, Therapy, Pharmaceutical industry

TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce year end 2023 results and audited financial statements.

Key Points: 
  • TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce year end 2023 results and audited financial statements.
  • Cash used in operations of $1.38 million; an 81% reduction compared to $7.4 million in 2022.
  • “2023 was a tremendous year for Avicanna where we solidified of our leadership position in the Canadian medical cannabis sector through our proprietary products and the launch of MyMedi.ca.
  • We have successfully demonstrated the scalability of our revenues and made significant improvements in our fundamentals while advancing all our business pillars.

Pliant Therapeutics to Participate in Upcoming Investor Events

Retrieved on: 
Tuesday, April 2, 2024
Therapy, SAN, Conference, Interest, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced participation in the following April investor events.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced participation in the following April investor events.
  • 23rd Annual Needham Virtual Healthcare Conference Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer, and Éric Lefebvre, M.D., Pliant’s Chief Medical Officer, will participate in a fireside chat on Tuesday, April 9, 2024, at 11:45 a.m. Eastern Time.
  • Interested parties may access the live webcast of the Needham fireside chat by visiting the Investor Relations’ Events & Presentation page of Pliant’s website.
  • The webcast replay will be archived on the Pliant website for 30 days following the conclusion of the event.

SBA Opens Two Business Recovery Centers to Support Small Businesses Amid Francis Scott Key Bridge Collapse

Retrieved on: 
Monday, April 1, 2024
Francis Scott Key Bridge, Disaster recovery, Speech, Telecommunications, SBA, Hearing, Interest, EIDL, Insurance

“Our Business Recovery Centers are one of the most powerful resources at SBA’s disposal to support business owners in the midst of a disaster,” said Francisco Sánchez, Jr., Associate Administrator for the SBA Office of Disaster Recovery and Resilience.

Key Points: 
  • “Our Business Recovery Centers are one of the most powerful resources at SBA’s disposal to support business owners in the midst of a disaster,” said Francisco Sánchez, Jr., Associate Administrator for the SBA Office of Disaster Recovery and Resilience.
  • “Business owners can meet in person with our specialists to apply for SBA disaster loans and get information on the full breadth of our programs designed to help them navigate their recovery.”
    On March 30, the SBA issued a disaster declaration covering counties affected by the Francis Scott Key Bridge collapse.
  • The declaration applies to small businesses, small agricultural cooperatives, small aquaculture businesses, and private nonprofit organizations.
  • Applicants may also call SBA’s Customer Service Center at (800) 659-2955 or email [email protected] for more information on SBA disaster assistance.

OMNIQ ANNOUNCES 2023 REVENUE OF $81.4 MILLION

Retrieved on: 
Monday, April 1, 2024
Growth, Tax, AI, Fintech, Impairment, Interest, Safety, Artificial intelligence, Cryptocurrency

OMNIQ reported revenue of $16 million for the quarter ended December 31, 2023.

Key Points: 
  • OMNIQ reported revenue of $16 million for the quarter ended December 31, 2023.
  • Cash balance on December 31, 2023, was approximately $1.7 million compared with $1.1 million on December 31, 2022.
  • OMNIQ reported revenue of $81.1 million for the year ended December 31, 2023, a decrease of $19.6 million from $100.8 million for the year ended December 31, 2022.
  • Our Gross Profit decreased to $15.7 million in the year that ended December 31, 2023, compared to $22.1 million in 2022.

Clever Leaves Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Monday, April 1, 2024
Financial statement, Certification, HBI, Consolidated, Partnership, Accounting Standards Codification, Patient, Sale, RDC, Sales, Closing, GMP, Procurement, ASC, Traction, Interest, ATM, Security, Note, Investment, THC, Pharmaceutical industry

TOCANCIPÁ, Colombia, April 01, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, is reporting financial and operating results for the fourth quarter and full year ended December 31, 2023. All financial information is provided in US dollars unless otherwise indicated.

Key Points: 
  • Subsequent to the end of the fourth quarter, we completed the $1.5 million sale of our Portuguese farm assets.
  • As we progress into 2024, we remain focused on driving further capital preservation and operational efficiencies.”
    Fourth Quarter 2023 Summary vs.
  • Same Year-Ago Quarter1
    Revenue in the fourth quarter of 2023 increased 5% to $4.6 million compared to $4.4 million for the same period in 2022.
  • Net loss in 2023 includes a $3.7 million loss on investment related to the fourth quarter sale of the Company’s remaining Cansativa stake.

Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Retrieved on: 
Monday, April 1, 2024
SAN, Conference, Interest, Cytokinetics

SOUTH SAN FRANCISCO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024 at 2:15 PM Eastern Time.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024 at 2:15 PM Eastern Time.
  • Interested parties may access the live webcast of this fireside chat by visiting the Investors & Media section of the Cytokinetics website at http://www.cytokinetics.com .
  • The webcast replay will be archived on the Cytokinetics website for 90 days following the conclusion of the event.

Goodness Growth Holdings Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Monday, April 1, 2024
Interest, International, Goodness, Tenant, Sale, Treasury, Toll, Event, Biomass, Property management

MINNEAPOLIS, April 01, 2024 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and great value to its customers, today reported financial results for its fourth quarter and full year ended December 31, 2023. Key financial results are presented below in summary form with supporting commentary and discussion from management of certain key operating metrics which the Company uses to judge its performance. All currency figures referenced herein are denominated in U.S. dollars.

Key Points: 
  • 2"A Flower" refers to produced biomass that meet the Company's highest internal standards for flower quality, size, and appearance.
  • As of December 31, 2023, total current assets were $148.9 million, including cash on hand of $16.0 million.
  • As of December 31, 2023, the Company had a total of 232,799,343 shares outstanding on the treasury method basis.
  • ET (3:30 p.m. CT) to discuss its financial results for its fourth quarter and full year ended December 31, 2023.

Telesat and Government of Canada Agree to Terms on C$2.14 Billion Loan in Support of Telesat Lightspeed

Retrieved on: 
Monday, April 1, 2024
LEO, Government, Letter, Documentation, Growth, Speed of light, Goldberg, History, TSAT, TSX, Interest, Communications satellite

The letter states that, following several months of negotiations between Telesat and federal officials, the Government of Canada (GoC) is prepared to invest C$2.14 billion in Telesat Lightspeed by way of a loan to Telesat LEO Inc., a wholly owned subsidiary of Telesat, that is developing and will own and operate the highly advanced Telesat Lightspeed Low Earth Orbit (LEO) global broadband satellite constellation.

Key Points: 
  • The letter states that, following several months of negotiations between Telesat and federal officials, the Government of Canada (GoC) is prepared to invest C$2.14 billion in Telesat Lightspeed by way of a loan to Telesat LEO Inc., a wholly owned subsidiary of Telesat, that is developing and will own and operate the highly advanced Telesat Lightspeed Low Earth Orbit (LEO) global broadband satellite constellation.
  • The loan will carry a floating interest rate that is 4.75% above the Canadian Overnight Repo Rate Average (CORRA) with a 15-year maturity.
  • Interest is payable in-kind during the Telesat Lightspeed construction period, followed by a 10-year sculpted amortization.
  • Furthermore, Telesat LEO Inc. will provide the GoC with warrants for 10% of the common shares of Telesat LEO based upon an equity valuation for Telesat LEO of US$3 billion.

Sachem Capital Reports Full Year 2023 Results

Retrieved on: 
Monday, April 1, 2024
Real estate investing, Tax, Interest, Growth, Weakness, Partnership, Telephone, Webcast, REIT, Wells Fargo Advisors, Investment, CPA, Cryptocurrency

BRANFORD, Conn., April 01, 2024 (GLOBE NEWSWIRE) -- Sachem Capital Corp. (NYSE American: SACH) announced its financial results for the year ended December 31, 2023. The Company will host a conference call on Monday, April 1, 2024 at 8:00 a.m. Eastern Time to discuss its financial and operating results.

Key Points: 
  • BRANFORD, Conn., April 01, 2024 (GLOBE NEWSWIRE) -- Sachem Capital Corp. (NYSE American: SACH) announced its financial results for the year ended December 31, 2023.
  • For the year ended 2023, interest income was $49.3 million compared to $42.6 million for the 2022 period.
  • Total operating costs and expenses for the year ended December 31, 2023 were $49.7 million, compared to $31.4 million for the 2022 period.
  • Total shareholders’ equity at December 31, 2023 rose $12.4 million to $230.1 million compared to $217.7 million at December 31, 2022.

SBA Offers Economic Assistance to Mid-Atlantic Small Businesses Affected by the Francis Scott Key Bridge Collapse

Retrieved on: 
Saturday, March 30, 2024
Letter, SBA, EIDL, Transport, Port of Baltimore, Disaster recovery, Interest, Speech, Telecommunications, Customer service, Movement, Hearing, Francis Scott Key Bridge

WASHINGTON, March 30, 2024 (GLOBE NEWSWIRE) -- Today, SBA Administrator Isabel Casillas Guzman announced that Mid-Atlantic small businesses affected by the Francis Scott Key Bridge collapse on March 26, 2024 may apply for low-interest, long-term Economic Injury Disaster Loans (EIDLs) from the U.S. Small Business Administration (SBA) .

Key Points: 
  • WASHINGTON, March 30, 2024 (GLOBE NEWSWIRE) -- Today, SBA Administrator Isabel Casillas Guzman announced that Mid-Atlantic small businesses affected by the Francis Scott Key Bridge collapse on March 26, 2024 may apply for low-interest, long-term Economic Injury Disaster Loans (EIDLs) from the U.S. Small Business Administration (SBA) .
  • “The SBA joins the entire federal family in grieving for the lives lost in the tragic collapse of the Francis Scott Key Bridge,” said Administrator Guzman.
  • The declaration applies to small businesses, small agricultural cooperatives, small aquaculture businesses, and private nonprofit organizations.
  • “The bridge collapse will impact small businesses who depend on the transportation and movement of goods from the Baltimore Harbor and along the Francis Scott Key Bridge for their economic livelihood,” said Francisco Sánchez, Jr., Associate Administrator for the SBA’s Office of Disaster Recovery and Resilience .